{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:09:08Z","timestamp":1769576948137,"version":"3.49.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Acute kidney injury resulting from ischemia\/reperfusion injury (IRI) remains a significant clinical challenge, with limited therapeutic options. This study investigated the renoprotective mechanisms of dapagliflozin, a sodium-glucose cotransporter 2 inhibitor (SGLT2i), in nondiabetic mice, focusing on neutrophil dynamics and adenosine signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Nondiabetic mice were pretreated with dapagliflozin before bilateral renal IRI. Some groups received concurrent treatment with an adenosine A2A receptor antagonist. We used novel multiphoton intravital imaging, complemented by comprehensive molecular and metabolomic analyses, to visualize neutrophil trafficking during early reperfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Dapagliflozin significantly attenuated renal dysfunction (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01) and histological damage (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01). Real-time imaging revealed that dapagliflozin markedly suppressed neutrophil infiltration into the glomeruli and peritubular capillaries during early reperfusion, and this effect was partially reversed by coadministration of an A2A receptor antagonist. Molecular analyses demonstrated reduced matrix metalloproteinase-9 expression and activity, with decreased levels of endothelial adhesion molecules, including intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Kidney adenosine levels were significantly increased in dapagliflozin-treated mice and were inversely correlated with matrix metalloproteinase-9 activity. Metabolome analysis revealed significant metabolic reprogramming characterized by suppressed glycolysis, enhanced tricarboxylic acid cycle activity, and elevated adenosine pathway components.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Dapagliflozin protects against renal IRI through the adenosine-mediated inhibition of neutrophil infiltration and inflammatory activation. This novel mechanism, involving metabolic reprogramming and enhanced adenosine signaling, extends our understanding of the pleiotropic effects of sodium-glucose cotransporter 2 inhibitors beyond glycemic control and suggests potential therapeutic applications for preventing acute kidney injury in high-risk clinical settings, including kidney transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005557","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:00:17Z","timestamp":1762437617000},"page":"e385-e394","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Adenosine-mediated Neutrophil Regulation by Dapagliflozin Attenuates Renal Ischemia\/Reperfusion Injury: Real-time Imaging and Metabolic Insights"],"prefix":"10.1097","volume":"110","author":[{"given":"Tomoaki","family":"Yamanoi","sequence":"first","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Kidokoro","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Hypertension, Kawasaki Medical School, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Sadahira","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Sekito","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."},{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasumi","family":"Yoshinaga","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."},{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Mitsui","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsushi","family":"Kawada","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Tominaga","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Bekku","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyohiko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kashihara","sequence":"additional","affiliation":[{"name":"Department of General Geriatric Medicine, Kawasaki Geriatric Medical Center, Kawasaki Medical School, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoo","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"R1-20260127","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","article-title":"Acute kidney injury.","volume":"7","author":"Kellum","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260127","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: current concepts, epidemiology.","volume":"96","author":"Peerapornratana","year":"2019","journal-title":"Kidney Int"},{"key":"R3-20260127","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.3390\/ijms25115924","article-title":"Acute kidney injury in sepsis.","volume":"25","author":"Pais","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R4-20260127","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/toxins12060361","article-title":"Endothelial damage, inflammation and immunity in chronic kidney disease.","volume":"12","author":"Diaz-Ricart","year":"2020","journal-title":"Toxins"},{"key":"R5-20260127","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/jcm10173798","article-title":"Targeting oxidative stress in septic acute kidney injury: from theory to practice.","volume":"10","author":"Ow","year":"2021","journal-title":"J Clin Med"},{"key":"R6-20260127","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.kint.2017.08.014","article-title":"Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia\/reperfusion-induced acute kidney injury.","volume":"93","author":"Raup-Konsavage","year":"2018","journal-title":"Kidney Int"},{"key":"R7-20260127","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/TP.0000000000003803","article-title":"Evaluation of neutrophil dynamics change by protective effect of tadalafil after renal ischemia\/reperfusion using in vivo real-time imaging.","volume":"106","author":"Maruyama","year":"2022","journal-title":"Transplantation"},{"key":"R8-20260127","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/labinvest.2010.174","article-title":"Inhibition of matrix metalloproteinases reduces ischemia-reperfusion acute kidney injury.","volume":"91","author":"Kunugi","year":"2011","journal-title":"Lab Invest"},{"key":"R9-20260127","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1097\/TP.0000000000004221","article-title":"Updated views on neutrophil responses in ischemia-reperfusion injury.","volume":"106","author":"Shepherd","year":"2022","journal-title":"Transplantation"},{"key":"R10-20260127","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.tp.0000198736.69527.32","article-title":"Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time.","volume":"81","author":"Araki","year":"2006","journal-title":"Transplantation"},{"key":"R11-20260127","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/S0002-9440(10)63065-9","article-title":"Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia\/reperfusion injury.","volume":"159","author":"Miura","year":"2001","journal-title":"Am J Pathol"},{"key":"R12-20260127","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/TP.0b013e31827d62b5","article-title":"Intravital imaging of neutrophil recruitment in hepatic ischemia-reperfusion injury in mice.","volume":"95","author":"Honda","year":"2013","journal-title":"Transplantation"},{"key":"R13-20260127","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1097\/TP.0000000000003405","article-title":"Live confocal imaging as a novel tool to assess liver quality: insights from a murine model.","volume":"104","author":"Cardini","year":"2020","journal-title":"Transplantation"},{"key":"R14-20260127","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/TP.0000000000001557","article-title":"Imaging leukocyte responses in the kidney.","volume":"101","author":"Finsterbusch","year":"2017","journal-title":"Transplantation"},{"key":"R15-20260127","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy.","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"R16-20260127","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease.","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"R17-20260127","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2409183","article-title":"Long-term effects of empagliflozin in patients with chronic kidney disease.","volume":"392","author":"Herrington","year":"2025","journal-title":"N Engl J Med"},{"key":"R18-20260127","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/ajh\/hpae092","article-title":"State-of-the-art-review: mechanisms of action of SGLT2 inhibitors and clinical implications.","volume":"37","author":"Vallon","year":"2024","journal-title":"Am J Hypertens"},{"key":"R19-20260127","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.3390\/ijms25137057","article-title":"The renoprotective mechanisms of sodium-glucose cotransporter-2 inhibitors (SGLT2i)\u2014a narrative review.","volume":"25","author":"Iordan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R20-20260127","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/dom.13754","article-title":"Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials.","volume":"21","author":"Gilbert","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"R21-20260127","doi-asserted-by":"crossref","first-page":"19323","DOI":"10.1038\/s41598-022-24103-x","article-title":"Empagliflozin protects against renal ischemia\/reperfusion injury in mice.","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"R22-20260127","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.kint.2018.05.002","article-title":"A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice.","volume":"94","author":"Zhang","year":"2018","journal-title":"Kidney Int"},{"key":"R23-20260127","doi-asserted-by":"crossref","first-page":"e0158810","DOI":"10.1371\/journal.pone.0158810","article-title":"Dapagliflozin, SGLT2 inhibitor, attenuates renal ischemia-reperfusion injury.","volume":"11","author":"Chang","year":"2016","journal-title":"PLoS One"},{"key":"R24-20260127","doi-asserted-by":"crossref","first-page":"20386","DOI":"10.1038\/s41598-024-71416-0","article-title":"SGLT2 inhibition mitigates transition from acute kidney injury to chronic kidney disease by suppressing ferroptosis.","volume":"14","author":"Hirashima","year":"2024","journal-title":"Sci Rep"},{"key":"R25-20260127","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","article-title":"Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using in vivo imaging.","volume":"140","author":"Kidokoro","year":"2019","journal-title":"Circulation"},{"key":"R26-20260127","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.RES.0000241428.82502.d4","article-title":"Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP\/PKA\/Ca2+ pathway.","volume":"99","author":"Ernens","year":"2006","journal-title":"Circ Res"},{"issue":"Suppl 2","key":"R27-20260127","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.23876\/j.krcp.22.011","article-title":"Adenosine receptors as emerging therapeutic targets for diabetic kidney disease.","volume":"41","author":"Pak","year":"2022","journal-title":"Kidney Res Clin Pract"},{"key":"R28-20260127","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/apha.12508","article-title":"Adenosine 2A receptors in acute kidney injury.","volume":"214","author":"Vincent","year":"2015","journal-title":"Acta Physiol (Oxf)"},{"key":"R29-20260127","first-page":"e62749","article-title":"An effective mouse model of unilateral renal ischemia-reperfusion injury.","volume":"173","author":"Godoy","year":"2021","journal-title":"J Vis Exp"},{"key":"R30-20260127","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation.","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"R31-20260127","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics.","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R32-20260127","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1159\/000489366","article-title":"Delayed ischemic preconditioning attenuated renal ischemia-reperfusion injury by inhibiting dendritic cell maturation.","volume":"46","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R33-20260127","doi-asserted-by":"crossref","first-page":"112260","DOI":"10.1016\/j.ejmech.2020.112260","article-title":"Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview.","volume":"194","author":"Mondal","year":"2020","journal-title":"Eur J Med Chem"},{"key":"R34-20260127","doi-asserted-by":"crossref","first-page":"F101","DOI":"10.1152\/ajprenal.00445.2010","article-title":"MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury.","volume":"301","author":"Lee","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"R35-20260127","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12882-021-02396-w","article-title":"Up-regulation of matrix metalloproteinases-9 in the kidneys of diabetic rats and the association with neutrophil gelatinase-associated lipocalin.","volume":"22","author":"Yang","year":"2021","journal-title":"BMC Nephrol"},{"key":"R36-20260127","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/0886022X.2021.1930558","article-title":"MMP-9-mediated regulation of hypoxia-reperfusion injury-related neutrophil inflammation in an in vitro proximal tubular cell model.","volume":"43","author":"Dong","year":"2021","journal-title":"Ren Fail"},{"key":"R37-20260127","first-page":"1","article-title":"Lack of matrix metalloproteinase-9 impairs neutrophil degranulation and prevents liver damage in mice.","volume":"3","author":"Oliveira","year":"2023","journal-title":"Int J Gastroenterol Liver Dis"},{"key":"R38-20260127","doi-asserted-by":"crossref","first-page":"111312","DOI":"10.1016\/j.cellsig.2024.111312","article-title":"Unveiling the bidirectional role of MMP9: a key player in kidney injury.","volume":"122","author":"Pang","year":"2024","journal-title":"Cell Signal"},{"key":"R39-20260127","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art.","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol Rev"},{"key":"R40-20260127","doi-asserted-by":"crossref","first-page":"1429736","DOI":"10.3389\/fcell.2024.1429736","article-title":"Adenosine-mediated immune responses in inflammatory bowel disease.","volume":"12","author":"Vuerich","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"R41-20260127","doi-asserted-by":"crossref","first-page":"F828","DOI":"10.1152\/ajprenal.00310.2005","article-title":"Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.","volume":"290","author":"Awad","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"R42-20260127","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11302-021-09786-7","article-title":"Neutrophils: fast and furious-the nucleotide pathway.","volume":"17","author":"Rubenich","year":"2021","journal-title":"Purinergic Signal"},{"key":"R43-20260127","doi-asserted-by":"crossref","first-page":"891570","DOI":"10.3389\/fimmu.2022.891570","article-title":"Elevated expression of TLR2 in aging hearts exacerbates cardiac inflammatory response and adverse remodeling following ischemia and reperfusion injury.","volume":"13","author":"Zhai","year":"2022","journal-title":"Front Immunol"},{"key":"R44-20260127","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1067\/mai.2003.1501","article-title":"Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma.","volume":"111","author":"Lee","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R45-20260127","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/CS20231752","article-title":"miR-486-5p protects against rat ischemic kidney injury and prevents the transition to chronic kidney disease and vascular dysfunction.","volume":"138","author":"Douvris","year":"2024","journal-title":"Clin Sci (Lond)"},{"key":"R46-20260127","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12933-018-0749-1","article-title":"Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.","volume":"17","author":"Nasiri-Ansari","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"R47-20260127","doi-asserted-by":"crossref","first-page":"110487","DOI":"10.1016\/j.mce.2019.110487","article-title":"Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice.","volume":"494","author":"Dimitriadis","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"R48-20260127","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.kint.2018.08.030","article-title":"Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease.","volume":"95","author":"Kikuchi","year":"2019","journal-title":"Kidney Int"},{"key":"R49-20260127","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.kint.2018.04.025","article-title":"Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice.","volume":"94","author":"Tanaka","year":"2018","journal-title":"Kidney Int"},{"key":"R50-20260127","doi-asserted-by":"crossref","first-page":"e22078","DOI":"10.1096\/fj.202100909RR","article-title":"SGLT2 inhibitor counteracts NLRP3 inflammasome via tubular metabolite itaconate in fibrosis kidney.","volume":"36","author":"Ke","year":"2022","journal-title":"FASEB J"},{"key":"R51-20260127","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/jcsm.13350","article-title":"Improved endurance capacity of diabetic mice during SGLT2 inhibition: role of AICARP, an AMPK activator in the soleus.","volume":"14","author":"Nakamura","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R52-20260127","doi-asserted-by":"crossref","first-page":"111811","DOI":"10.1016\/j.jclinane.2025.111811","article-title":"The effects of sodium-glucose transporter 2 inhibition on cardiac surgery-associated acute kidney injury: an open-label randomized pilot study.","volume":"103","author":"Snel","year":"2025","journal-title":"J Clin Anesth"},{"key":"R53-20260127","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2215\/CJN.0000000000000196","article-title":"Pharmacokinetic properties of dapagliflozin in hemodialysis and peritoneal dialysis patients.","volume":"18","author":"Barreto","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"R54-20260127","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1097\/TP.0000000000003679","article-title":"Advances in kidney preservation techniques and their application in clinical practice.","volume":"105","author":"Hosgood","year":"2021","journal-title":"Transplantation"},{"key":"R55-20260127","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.kint.2021.04.001","article-title":"Metabolic needs of the kidney graft undergoing normothermic machine perfusion.","volume":"100","author":"Arykbaeva","year":"2021","journal-title":"Kidney Int"},{"key":"R56-20260127","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/TP.0000000000004269","article-title":"Abdominal organ preservation solutions in the age of machine perfusion.","volume":"107","author":"Ramos","year":"2023","journal-title":"Transplantation"},{"key":"R57-20260127","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamasurg.2025.0940","article-title":"Postoperative outcomes among sodium-glucose cotransporter 2 inhibitor users.","volume":"160","author":"Tallarico","year":"2025","journal-title":"JAMA Surg"},{"key":"R58-20260127","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1097\/TP.0000000000004228","article-title":"The efficacy and safety of SGLT2 inhibitor in diabetic kidney transplant recipients.","volume":"106","author":"Lim","year":"2022","journal-title":"Transplantation"},{"key":"R59-20260127","doi-asserted-by":"crossref","first-page":"20420188221090001","DOI":"10.1177\/20420188221090001","article-title":"Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?","volume":"13","author":"Ujjawal","year":"2022","journal-title":"Ther Adv Endocrinol Metab"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:00:36Z","timestamp":1769511636000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005557","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]}}}